Qtron Investments’s Halozyme HALO Stock Holding History

Qtron Investments’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$425K	Sell	5,434 -1,726	-24%	-$118K	0.06%	362
2026 Q1	$463K	Hold	7,160	–	–	0.06%	345
2025 Q4	$482K	Buy	+7,160	New	+$482K	0.06%	335
2021 Q3	–	Sell	-5,624	Closed	-$255K	–	325
2021 Q2	$255K	Hold	5,624	–	–	0.06%	294
2021 Q1	$234K	Buy	+5,624	New	+$257K	0.07%	295

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Qtron Investments's HALO Position: Q2 2026 in Review

Qtron Investments reduced its Halozyme (HALO) stake by 24% in Q2 2026, selling an estimated $118K and leaving 5,434 shares worth $425K. The position accounts for 0.06% of the portfolio, ranked #362.

Qtron Investments first reported a position in HALO in Q1 2021 and has held it in 5 quarters since. The position peaked at $482K in Q4 2025. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Qtron Investments held 5,434 shares of Halozyme worth $425K as of Q2 2026.
Qtron Investments sold 1,726 Halozyme shares in Q2 2026, an estimated $118K.
Halozyme made up 0.06% of Qtron Investments's portfolio in Q2 2026, its #362 holding.
Qtron Investments first reported a position in Halozyme in Q1 2021 and has held it in 5 quarters since.
Qtron Investments's Halozyme position peaked at $482K in Q4 2025.
672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.